Cargando…
A novel PDGF receptor inhibitor-eluting stent attenuates in-stent neointima formation in a rabbit carotid model
A novel drug-eluting stent (DES) is required to target vascular smooth muscle cells (SMCs) without harming endothelial cells (ECs). Platelet-derived growth factor (PDGF) is critical for the proliferation and migration of SMCs. Sunitinib [a PDGF receptor (PDGFR) tyrosine kinase inhibitor]-eluting ste...
Autores principales: | Huang, Chen, Mei, Haijun, Zhou, Min, Zheng, Xiaobing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355735/ https://www.ncbi.nlm.nih.gov/pubmed/27922693 http://dx.doi.org/10.3892/mmr.2016.5986 |
Ejemplares similares
-
Influence of valsartan-eluting stent on neointima formation
por: Guihua, Li, et al.
Publicado: (2010) -
Stents Eluting 6-Mercaptopurine Reduce Neointima Formation and Inflammation while Enhancing Strut Coverage in Rabbits
por: Ruiter, Matthijs S., et al.
Publicado: (2015) -
Endothelial cell repopulation after stenting determines in-stent neointima formation: effects of bare-metal vs. drug-eluting stents and genetic endothelial cell modification
por: Douglas, Gillian, et al.
Publicado: (2013) -
Formation and Transformation of Neointima after Drug-eluting Stent Implantation: Insights from Optical Coherence Tomographic Studies
por: Lee, Seung-Yul, et al.
Publicado: (2017) -
Nanoporous CREG-Eluting Stent Attenuates In-Stent Neointimal Formation in Porcine Coronary Arteries
por: Deng, Jie, et al.
Publicado: (2013)